Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Molecular Partners AG

    NASDAQ: MOLN · Real-Time Price · USD
    3.64
    -0.01 (-0.27%)
    At close: Jun 05, 2025, 3:59 PM
    3.56
    -2.20%
    After-hours: Jun 05, 2025, 04:04 PM EDT

    Molecular Partners Statistics

    Share Statistics

    Molecular Partners has 36.87M shares outstanding. The number of shares has increased by 11.13% in one year.

    Shares Outstanding

    n/a
    		 36.87M

    Shares Change (YoY)

    n/a
    		 11.13%

    Shares Change (QoQ)

    n/a
    		 0.03%

    Owned by Institutions (%)

    n/a
    		 10.79%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,615

    FTD / Avg. Volume

    n/a
    		 14.63%

    Short Selling Information

    The latest short interest is 46.16K, so 0.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 46.16K

    Short % of Shares Out

    n/a
    		 0.13%

    Short % of Float

    n/a
    		 0.26%

    Short Ratio (days to cover)

    n/a
    		 12.88

    Valuation Ratios

    The PE ratio is -2.72 and the forward PE ratio is -2.09. Molecular Partners's PEG ratio is 0.17.

    PE Ratio

    n/a
    		 -2.72

    Forward PE

    n/a
    		 -2.09

    PS Ratio

    n/a
    		 29.53

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 1.04

    P/FCF Ratio

    n/a
    		 -2.45

    PEG Ratio

    n/a
    		 0.17
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Molecular Partners.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 14.31, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 14.31

    Quick Ratio

    n/a
    		 14.31

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -2448.68

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $31,455.7

    Profits Per Employee

    n/a
    		 $-342,044.3

    Employee Count

    n/a
    		 158

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 2K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -12.92% in the last 52 weeks. The beta is 0.52, so Molecular Partners's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.52

    52-Week Price Change

    n/a
    		 -12.92%

    50-Day Moving Average

    n/a
    		 3.92

    200-Day Moving Average

    n/a
    		 4.96

    Relative Strength Index (RSI)

    n/a
    		 42.64

    Average Volume (20 Days)

    n/a
    		 11,039

    Income Statement

    In the last 12 months, Molecular Partners had revenue of 4.97M and earned -54.04M in profits. Earnings per share was -1.59.

    Revenue

    n/a
    		 4.97M

    Gross Profit

    n/a
    		 4.97M

    Operating Income

    n/a
    		 -61.22M

    Net Income

    n/a
    		 -54.04M

    EBITDA

    n/a
    		 -51.65M

    EBIT

    n/a
    		 -54.02M

    Earnings Per Share (EPS)

    n/a
    		 -1.59
    Full Income Statement

    Balance Sheet

    The company has 63.87M in cash and 2.44M in debt, giving a net cash position of 61.43M.

    Cash & Cash Equivalents

    n/a
    		 63.87M

    Total Debt

    n/a
    		 2.44M

    Net Cash

    n/a
    		 61.43M

    Retained Earnings

    n/a
    		 -246.29M

    Total Assets

    n/a
    		 158.53M

    Working Capital

    n/a
    		 143.5M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -59.25M and capital expenditures -723K, giving a free cash flow of -59.97M.

    Operating Cash Flow

    n/a
    		 -59.25M

    Capital Expenditures

    n/a
    		 -723K

    Free Cash Flow

    n/a
    		 -59.97M

    FCF Per Share

    n/a
    		 -1.76
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1231.73% and -1087.38%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1231.73%

    Pretax Margin

    n/a
    		 -1087.34%

    Profit Margin

    n/a
    		 -1087.38%

    EBITDA Margin

    n/a
    		 -1039.18%

    EBIT Margin

    n/a
    		 -1231.73%

    FCF Margin

    n/a
    		 -1206.66%

    Dividends & Yields

    MOLN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MOLN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.5

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist